跳至主要内容
临床试验/CTRI/2025/08/093458
CTRI/2025/08/093458尚未招募Phase 3 4

COMPARISON OF DIFFERENT DOSES OF DEXMEDETOMIDINE AS ADJUVANT TO HYPERBARIC BUPIVACAINE IN SPINAL ANAESTHESIA FOR LOWER LIMB ORTHOPAEDIC SURGERIES

Government Multi Speciality Hospital1 个研究点 分布在 1 个国家目标入组 99 人开始时间: 2025年9月1日最近更新:

试验速览

阶段
Phase 3 4
状态
尚未招募
发起方
入组人数
99
试验地点
1
主要终点
To determine duration of analgesia

研究概览

简要总结

this is prospective double blind randomised controlled study. In patients, undergoing lower limb surgeries under spinal anaesthesia with hyperbaric bupivacaine, the study will compare the effect of adding two different doses of dexmedetomidine(3 microgram and 5 microgram) to hyperbaric bupivacaine in spinal anaesthesia for lower limb orthopaedic surgeries at government multispeciality hospital ,sec 16A ,chandigarh.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Double

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Age group 18 to 60 years 2)ASA physical status grade I and grade II 3)Weight 50 to 90 kg 4)Height 150 to 180 cm 5)Patients giving consent for the study.

排除标准

  • Patients with any contraindication to regional anaesthesia 2)Patients with a history of significant co existing diseases like uncontrolled diabetes , uncontrolled hypertension, ischaemic heart disease, recent myocardial infarction, heart block, impaired renal functions and severe liver disease.
  • Patients with spine deformities like Kyphoscoliosis, Scoliosis etc.
  • Patient with a history of allergy to the drugs to be used.
  • Patient on alpha2 agonist or antagonist therapy.

结局指标

主要结局

To determine duration of analgesia

时间窗: 12 Hours

次要结局

  • 1)To determine the onset and duration of sensory and motor blockade(2)To study the effect on haemodynamic parameters.)

研究者

发起方
Government Multi Speciality Hospital
申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Lalit kumar

Government Multi Speciality Hospital- 16, CHANDIGARH

研究点 (1)

Loading locations...

相似试验

Evaluating Various Doses of Dexmedetomidine with... | 临床试验